Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

Dyne Therapeutics, Inc.

Drug Discovery & Development
Headquarters—
Founded—
Last known round—
Reported valuation—

Security-class differences are disclosed on the affected rows; non-degenerate marks remain in the underlying-company comparison band. 2 rows are omitted from dispersion statistics under the degenerate-mark guard; each affected row states why.

Cross-fund comparison

Equity & warrant marks

One underlying-company band; one latest disclosed mark per fund and security.

FundFair valueSecurity / annotationsImplied price / shareMark age vs roundMethodology / filing
HTGCHercules Capital, Inc.$3.8MJun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.Omitted from statistics — Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.$22.21Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗

Cross-fund comparison

Debt investments

Included in the same underlying-company comparison band.

FundSecurity type / annotationsPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HTGCHercules Capital, Inc.senior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior SecuredFiled as senior secured loan; the comparison band's majority class is equity.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Omitted from statistics — security type is not an eligible fund-equity mark for dispersion.$142MJun 30, 2026 · source ↗$143.8MJun 30, 2026 · source ↗101.3%Jun 30, 2026 · source ↗Prime + 2.45%, Floor rate 9.95%, 5.50% Exit FeeJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗NoJun 30, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$143.8MHTGCJun 30, 2026 · source ↗$3.8MHTGCJun 30, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation